Cargando…
Vas deferens metastasis from prostate adenocarcinoma treated with daily-adaptive MR-guided SBRT on 1.5T MR-linac
Autores principales: | Vitale, Claudio, Nicosia, Luca, Pastorello, Edoardo, Rigo, Michele, Doraku, Joniada, Salgarello, Matteo, Alongi, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9591037/ https://www.ncbi.nlm.nih.gov/pubmed/36299380 http://dx.doi.org/10.5603/RPOR.a2022.0035 |
Ejemplares similares
-
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer
por: Nicosia, Luca, et al.
Publicado: (2022) -
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients
por: Alongi, Filippo, et al.
Publicado: (2022) -
Dosimetric analysis of MR‐LINAC treatment plans for salvage spine SBRT re‐irradiation
por: Han, Eun Young, et al.
Publicado: (2022) -
1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
por: Alongi, Filippo, et al.
Publicado: (2020) -
MR‐linac is the best modality for lung SBRT
por: Godley, Andrew, et al.
Publicado: (2019)